Market Place
Sourcing Support
Italfarmaco Partners With Iktos On AI To Speed Drug Discovery Breakthroughs
18 Jun 2024 //
GLOBENEWSWIRE
FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy
21 Mar 2024 //
PR NEWSWIRE
Results from Italfarmaco Pivotal Phase 3 EPIDYS Study of Givinostat in DMD
19 Mar 2024 //
BUSINESSWIRE
Nerviano and Italfarmaco Announce Licensing of Linker-Payload Technology
14 Dec 2023 //
BUSINESSWIRE
Italfarmaco Group Receives EMA Validation of MAA for Givinostat
05 Sep 2023 //
BUSINESSWIRE
Italfarmaco Acquires 100% of Lacer
27 Jul 2022 //
BUSINESSWIRE
Italfarmaco Group Announces Positive Topline Data from PIII Trial of Givinostat
25 Jun 2022 //
BUSINESSWIRE
Italfarmaco Announces Topline Data from Phase 2 Trial with Givinostat
26 Jun 2021 //
BUSINESSWIRE
Italfarmaco Announces Publication of Positive Long-term Data for Givinostat
18 Mar 2021 //
BUSINESSWIRE
Italfarmaco Group Enters Into an Agreement with Luye Pharma
16 Mar 2021 //
BIOSPACE
Italfarmaco Receives FDA Rare Pediatric Disease Designation for Givinostat
09 Oct 2020 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.